pattismith
Senior Member
- Messages
- 3,988
Autonomic and peripheral neuropathy with reduced intraepidermal nerve fiber density can be observed in patients with gastrointestinal dysmotility
Dec 2019
Abstract
Neuropathy should be considered as a possible etiological factor in patients with severe gastrointestinal symptoms, without signs of disease on routine investigations. Examinations of the autonomic and peripheral nervous systems may be helpful to select the patients who should be investigated with full‐thickness intestinal biopsy, and to give appropriate care.
1 INTRODUCTION
Severe gastrointestinal (GI) dysmotility in the form of chronic intestinal pseudo‐obstruction (CIPO) and enteric dysmotility (ED) are rare diseases, which are difficult to diagnose.1 Enteric neuropathy, leading to dysmotility, is seldom studied, since there are few centers available for evaluation of GI motility. Furthermore, there are difficulties to get access to myenteric plexus of the enteric nervous system, and the histopathological examination of tissue samples is time‐consuming.
Subsequently, most patients with GI dysmotility and pain are diagnosed to have irritable bowel syndrome (IBS), or the neuropathy diagnosis is delayed for several years.2, 3
Due to different treatment strategies between GI dysmotility and IBS, it is important to diagnose the diseases correctly. Functional bowel diseases are mainly treated with dietary advice in the form of regular meals with carbohydrate restriction and psychological therapy,4 whereas dysmotility is treated with prokinetic drugs and dietary supplemental therapy.5
Previous reports have shown signs of autonomic neuropathy and serum antibodies against neural components in patients with CIPO and ED.3, 6
Furthermore, autonomic and peripheral neuropathy are associated, for example, in diabetes mellitus.7
This has led to the hypothesis that examination of the autonomic and peripheral nervous systems could be used, to select candidates for full‐thickness intestinal biopsy, and to facilitate the differentiation between patients with neuropathic dysmotility and IBS.
The present double case report describes two women with severe GI dysmotility during several years, confirmed by examinations of GI motility and full‐thickness biopsy with immunohistochemical staining. In 2018, examinations with specific questionnaires regarding symptoms of autonomic and peripheral dysfunction, along with autonomic nerve function tests and skin biopsies, were performed to examine the autonomic and peripheral nervous systems.
Patients with gastrointestinal dysmotility may have symptoms and signs of a more generalized neuropathy. Besides examining the gut function, also the autonomic and peripheral nerve functions with determination of the intraepidermal nerve fiber density should be tested, to select patients for full‐thickness intestinal biopsies and to handle the patients appropriately.
Dec 2019
Abstract
Neuropathy should be considered as a possible etiological factor in patients with severe gastrointestinal symptoms, without signs of disease on routine investigations. Examinations of the autonomic and peripheral nervous systems may be helpful to select the patients who should be investigated with full‐thickness intestinal biopsy, and to give appropriate care.
1 INTRODUCTION
Severe gastrointestinal (GI) dysmotility in the form of chronic intestinal pseudo‐obstruction (CIPO) and enteric dysmotility (ED) are rare diseases, which are difficult to diagnose.1 Enteric neuropathy, leading to dysmotility, is seldom studied, since there are few centers available for evaluation of GI motility. Furthermore, there are difficulties to get access to myenteric plexus of the enteric nervous system, and the histopathological examination of tissue samples is time‐consuming.
Subsequently, most patients with GI dysmotility and pain are diagnosed to have irritable bowel syndrome (IBS), or the neuropathy diagnosis is delayed for several years.2, 3
Due to different treatment strategies between GI dysmotility and IBS, it is important to diagnose the diseases correctly. Functional bowel diseases are mainly treated with dietary advice in the form of regular meals with carbohydrate restriction and psychological therapy,4 whereas dysmotility is treated with prokinetic drugs and dietary supplemental therapy.5
Previous reports have shown signs of autonomic neuropathy and serum antibodies against neural components in patients with CIPO and ED.3, 6
Furthermore, autonomic and peripheral neuropathy are associated, for example, in diabetes mellitus.7
This has led to the hypothesis that examination of the autonomic and peripheral nervous systems could be used, to select candidates for full‐thickness intestinal biopsy, and to facilitate the differentiation between patients with neuropathic dysmotility and IBS.
The present double case report describes two women with severe GI dysmotility during several years, confirmed by examinations of GI motility and full‐thickness biopsy with immunohistochemical staining. In 2018, examinations with specific questionnaires regarding symptoms of autonomic and peripheral dysfunction, along with autonomic nerve function tests and skin biopsies, were performed to examine the autonomic and peripheral nervous systems.
Patients with gastrointestinal dysmotility may have symptoms and signs of a more generalized neuropathy. Besides examining the gut function, also the autonomic and peripheral nerve functions with determination of the intraepidermal nerve fiber density should be tested, to select patients for full‐thickness intestinal biopsies and to handle the patients appropriately.